Although pharmaceutical companies attempt to design and develop new chemical entities using rational and logical processes, very few of these compounds become clinically useful drugs because unpredictable interactions with biological systems reduces therapeutic efficacy and in many cases leads to undesirable toxicity. An alternative approach to enhance therapeutic activity relies on the chemical modification of known compounds to overcome the undesirable physical and chemical properties using pro-drug design.